LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Normalized Growth Rate Inhibition Value
SK-BR-3 AZD7762
1.11
uM
LJP6
 72
hr
 1401 1112 4168 0.2665 -0.1380
SK-BR-3 AZD7762
0.37
uM
LJP6
 72
hr
 1401 1341 4168 0.3216 -0.0285
SK-BR-3 AZD7762
0.12
uM
LJP6
 72
hr
 1401 1526 4168 0.3660 0.0552
SK-BR-3 AZD7762
0.04
uM
LJP6
 72
hr
 1401 1907 4168 0.4574 0.2158
SK-BR-3 AT-7519
10
uM
LJP6
 72
hr
 1401 486 4168 0.1167 -0.4930
SK-BR-3 AT-7519
3.33
uM
LJP6
 72
hr
 1401 711 4168 0.1708 -0.3524
SK-BR-3 AT-7519
1.11
uM
LJP6
 72
hr
 1401 953 4168 0.2287 -0.2181
SK-BR-3 AT-7519
0.37
uM
LJP6
 72
hr
 1401 1174 4168 0.2819 -0.1064
SK-BR-3 AT-7519
0.12
uM
LJP6
 72
hr
 1401 1469 4168 0.3528 0.0307
SK-BR-3 AT-7519
0.04
uM
LJP6
 72
hr
 1401 2511 4168 0.6031 0.4499
SK-BR-3 Seliciclib
10
uM
LJP5
 72
hr
 1401 2209 4245 0.5182 0.3213
SK-BR-3 Seliciclib
3.33
uM
LJP5
 72
hr
 1401 3235 4245 0.7609 0.6836
SK-BR-3 Seliciclib
1.11
uM
LJP5
 72
hr
 1401 3763 4245 0.8864 0.8542
SK-BR-3 Seliciclib
0.37
uM
LJP5
 72
hr
 1401 3923 4245 0.9229 0.9004
SK-BR-3 Seliciclib
0.12
uM
LJP5
 72
hr
 1401 4234 4245 0.9990 1.0004